[article] 
inJournal of Autism and Developmental Disorders > 46-6 (June 2016) . - p.1887-1894

Titre :	Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home
Type de document :	Texte imprimé et/ou numérique
Auteurs :	Lisa M. RUIZ, Auteur ; Mackenzie DAMRON, Auteur ; Kyle B. JONES, Auteur ; Dean WEEDON, Auteur ; Paul S. CARBONE, Auteur ; Amanda V. BAKIAN, Auteur ; Deborah A. BILDER, Auteur
Article en page(s) :	p.1887-1894
Langues :	Anglais (eng)
Mots-clés :	Antipsychotics  Autism spectrum disorder  Intellectual disability  Medical home
Index. décimale :	PER Périodiques
Résumé :	This study describes antipsychotic use and metabolic monitoring rates among individuals with developmental disabilities enrolled in a subspecialty medical home (N = 826). Four hundred ninety-nine participants (60.4 %) were taking antipsychotics, which was associated with male gender (p = 0.01), intellectual disability with and without autism spectrum disorder (p = 0.001 and p = 0.04, respectively), and inversely associated with the youngest and oldest age categories (p = 0.001 and p = 0.04, respectively). Among those taking antipsychotics, annual metabolic monitoring rates ranged from 89 % (lipids) to 99 % (weight). Age was positively associated with glucose (p < 0.001) and lipid monitoring (p < 0.001). Adult participants with dyslipidemia (p < 0.01), prediabetes/diabetes (p = 0.04), and hypertension (p = 0.02) were significantly more likely to obtain lipid monitoring. These values exceeded previously reported rates suggesting the importance of an integrated care model.
En ligne :	http://dx.doi.org/10.1007/s10803-016-2712-x
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=288

[article] Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home [Texte imprimé et/ou numérique] / Lisa M. RUIZ, Auteur ; Mackenzie DAMRON, Auteur ; Kyle B. JONES, Auteur ; Dean WEEDON, Auteur ; Paul S. CARBONE, Auteur ; Amanda V. BAKIAN, Auteur ; Deborah A. BILDER, Auteur . - p.1887-1894.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 46-6 (June 2016) . - p.1887-1894

Mots-clés :	Antipsychotics  Autism spectrum disorder  Intellectual disability  Medical home
Index. décimale :	PER Périodiques
Résumé :	This study describes antipsychotic use and metabolic monitoring rates among individuals with developmental disabilities enrolled in a subspecialty medical home (N = 826). Four hundred ninety-nine participants (60.4 %) were taking antipsychotics, which was associated with male gender (p = 0.01), intellectual disability with and without autism spectrum disorder (p = 0.001 and p = 0.04, respectively), and inversely associated with the youngest and oldest age categories (p = 0.001 and p = 0.04, respectively). Among those taking antipsychotics, annual metabolic monitoring rates ranged from 89 % (lipids) to 99 % (weight). Age was positively associated with glucose (p < 0.001) and lipid monitoring (p < 0.001). Adult participants with dyslipidemia (p < 0.01), prediabetes/diabetes (p = 0.04), and hypertension (p = 0.02) were significantly more likely to obtain lipid monitoring. These values exceeded previously reported rates suggesting the importance of an integrated care model.
En ligne :	http://dx.doi.org/10.1007/s10803-016-2712-x
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=288